Beck Bode LLC’s Corteva CTVA Stock Holding History

Beck Bode LLC’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-737	Closed	-$33K	–	134
2021 Q2	$33K	Buy	+737	New	+$34K	0.01%	157
2020 Q4	–	Sell	-779	Closed	-$22K	–	68
2020 Q3	$22K	Buy	+779	New	+$21.9K	0.01%	159

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Beck Bode LLC's CTVA Position: Q3 2021 in Review

Beck Bode LLC sold out of Corteva (CTVA) in Q3 2021, closing a stake of 737 shares — an estimated $33K sold.

Beck Bode LLC first reported a position in CTVA in Q3 2020 and held it in 2 quarters. The position peaked at $33K in Q2 2021. 1,039 funds tracked by Wall St. Rank hold CTVA as of Q3 2021.

Beck Bode LLC reported no remaining Corteva position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 737 Corteva shares in Q3 2021, an estimated $33K.
Beck Bode LLC first reported a position in Corteva in Q3 2020 and held it in 2 quarters.
Beck Bode LLC's Corteva position peaked at $33K in Q2 2021.
1,039 funds tracked by Wall St. Rank held Corteva as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.